Anticardiolipin antibodies and thromboembolism after BMT

Bone Marrow Transplant. 1998 Apr;21(8):845-7. doi: 10.1038/sj.bmt.1701184.

Abstract

We describe a 4-month-old child who developed unusual thrombotic complications following allogeneic BMT for Omenn syndrome, a form of SCID. Eight weeks after the procedure the child suffered a major cerebrovascular accident and developed acute pulmonary hypertension in association with persistently elevated anticardiolipin antibody titres. It is postulated that central line-derived microemboli caused these serious thrombotic complications in the context of an evolving hypercoaguable state.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Anticardiolipin / blood*
  • Bone Marrow Transplantation / adverse effects*
  • Catheterization, Central Venous / adverse effects*
  • Humans
  • Infant
  • Male
  • Severe Combined Immunodeficiency / therapy*
  • Thromboembolism / etiology*

Substances

  • Antibodies, Anticardiolipin